Form 4: Humana Director Marcy Klevorn Boosts Stock Unit Holdings

Humana Director Marcy Klevorn increased her beneficial ownership of the company's stock units through annual fees and dividend reinvestment, deferring payout until her resignation.

Summary

• Marcy S. Klevorn, a Director of Humana Inc., acquired 766 Restricted Stock Units (RSUs) as an annual director's fee on January 2, 2026.
• An additional 28 Restricted Stock Units were acquired on December 31, 2025, through dividend reinvestment on vested and deferred stock units.
• The 766 RSUs were acquired at a price of $0, while the 28 RSUs from dividend reinvestment were acquired at $258.8675 per unit.
• Both sets of acquired stock units are deferred until Klevorn's resignation as a director, at which point they will be payable in Humana Inc. common stock on a 1-for-1 basis.
• Following these transactions, Klevorn directly owns 436 shares of Humana Common Stock.
• Klevorn's beneficial ownership of derivative securities now includes 2,771 Restricted Stock Units (from annual fees) and 53 Restricted Stock Units (from dividend reinvestment).

Sentiment

Score: 7

Explanation: The filing indicates a routine increase in a director's beneficial ownership through compensation and reinvestment, which generally signals continued commitment and alignment with shareholder interests, contributing to a slightly positive sentiment.

Positives

• The acquisition of additional stock units by a director demonstrates continued commitment and alignment of interests with long-term shareholder value.
• The deferral of stock unit payouts until resignation encourages long-term engagement and strategic oversight from the director.

Future Outlook

The acquired stock units are deferred and will be payable in Humana Inc. common stock on a 1-for-1 basis upon Marcy S. Klevorn's resignation of services as a director.

Management Comments

• Annual Director's fee payable in stock units has been deferred at the election of the Reporting Person until her resignation of services as a director, at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis.
• Director's dividend payment was reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director, at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis.

Industry Context

The acquisition of stock units as part of director compensation and through dividend reinvestment is a standard practice in publicly traded companies, particularly within the healthcare and insurance sectors, aiming to align director incentives with long-term shareholder value.

Comparison to Industry Standards

• Director compensation structured with equity awards and dividend reinvestment plans is a common corporate governance practice across global benchmarks, including major U.S. and international companies.
• This approach is consistent with best practices observed in the healthcare industry, where companies like UnitedHealth Group (UNH) and Anthem (ANTM) also utilize equity-based compensation to incentivize their leadership.
• The deferral of payout until resignation is a mechanism often employed to ensure sustained commitment and long-term strategic focus from board members, aligning with governance standards seen in mature markets.

Stakeholder Impact

• Shareholders: Increased alignment of a director's financial interests with long-term shareholder value due to increased equity ownership and deferred payout.

Next Steps

• The acquired stock units will be paid out in Humana Inc. common stock on a 1-for-1 basis upon Marcy S. Klevorn's resignation as a director.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to director compensation and dividend reinvestment. While it shows continued director alignment with shareholder interests, it does not present new information that would fundamentally alter the investment thesis for Humana Inc. Therefore, a 'hold' recommendation is appropriate based solely on this filing, awaiting more comprehensive financial or strategic updates.

Keywords

Humana, HUM, Form 4, Insider Transaction, Director Compensation, Restricted Stock Units, Equity Ownership, Beneficial Ownership, Dividend Reinvestment